Virtual Hospital Diabetes Meeting

Meeting Agenda (All Times are Pacific)

Friday, April 1, 2022

SESSION 1: DIGITAL HEALTH AND THE HOSPITAL (7:00–8:20 AM)

Moderator

Signe Schmidt, MD, PhD
Steno Diabetes Center Copenhagen, Gentofte, Denmark

7:00

Machine Learning Glycemic Predictions For the Hospital Using EHR Data

Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA

7:15

Order Sets and Other Strategies in the EHR to Prevent Harm

Andrew Demidowich, MD
Johns Hopkins University, Baltimore, Maryland, USA

7:30

Customizing the EHR for Diabetes

Kensaku Kawamoto, MD, PhD, MHS
University of Utah, Salt Lake City, Utah, USA

7:45

Integration of CGM Sensor Data into the EHR

Juan Espinoza, MD, FAAP
Children’s Hospital Los Angeles, USC, Los Angeles, California, USA

8:00

Q&A / Panel Discussion

8:20

Break

SESSION 2: BLOOD GLUCOSE TARGETS (8:40–10:00 AM)

Moderator

Francisco J. Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA

8:40

CMS Glycemic Management Measures: What They Will Do (and What They Won’t Do) to Improve Care

Gregory A. Maynard, MD, MSc, MHM
University of California, Davis, Sacramento, California, USA

8:55

ICU Targets for Glycemia

Jean-Charles Preiser, MD, PhD
Erasme University Hospital, Brussels, Belgium

9:10

How to Reach Glycemic Targets in the Real World

Andjela T. Drincic, MD, FACP
University of Nebraska, Omaha, Nebraska, USA

9:25

Accuracy of BGM Systems in the Hospital

James H. Nichols, PhD, DABCC, FAACC
Vanderbilt University Medical Center, Nashville, Tennessee, USA

9:40

Q&A / Panel Discussion

10:00

Break

SESSION 3: SOFTWARE FOR INPATIENT DIABETES (10:25 AM–12:05 PM)

Moderators

Andjela T. Drincic, MD, FACP
University of Nebraska, Omaha, Nebraska, USA

Gerlies M. Treiber, MD
Medical University of Graz, Graz, Austria

10:25

Home Grown Insulin Dosing Software

Kristen M. Kulasa, MD
University of California, San Diego, La Jolla, California, USA

10:40

Commercial Insulin Dosing Software

Joseph A. Aloi, MD
Wake Forest Baptist Health, Winston-Salem, North Carolina, USA

10:55

Commercial Insulin Dosing Software

Matthew F. Bouchonville, MD, CDCES
University of New Mexico, Albuquerque, New Mexico, USA

11:10

IT Issues with Building Home Grown Insulin Dosing Software

Robert J. Rushakoff, MD
University of California, San Francisco, San Francisco, California, USA

11:25

Intellectual Property Considerations for Home Grown Insulin Dosing Software

Raymond R. Moser, MSEE, JD
Moser Taboada, Shrewsbury, New Jersey, USA

11:40

Q&A / Panel Discussion

12:05

Break

SESSION 4: SURGERY (12:30–1:50 PM)

Moderator

M. Cecilia Lansang, MD, MPH
Cleveland Clinic, Cleveland, Ohio, USA

12:30

Preoperative Assessment

Kathleen Dungan, MD, MPH
The Ohio State University, Columbus, Ohio, USA

12:45

Preoperative Management and ERAS

Marie E. McDonnell, MD
Brigham & Women’s Hospital, Boston, Massachusetts, USA

1:00

Managing Orthopedic Surgery Patients

Ruben Diaz, DNP, FNP-BC, BC-ADM, CDCES
Memorial Sloan Kettering Cancer Center, New York City, New York, USA

1:15

Foot Surgery

David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA

1:30

Q&A / Panel Discussion

1:50

Break

SESSION 5: TRANSITIONS (2:10–3:30 PM)

Moderator

Umesh Masharani, MD
University of California, San Francisco, San Francisco, California, USA

2:10

Prediction Models for Adverse Glycemia

Mervyn Kyi, MBBS (Hons), FRACP, PhD
Royal Melbourne Hospital, Parkville, Victoria, Australia

2:25

The Effects of Acute and Chronic Glycemia and Prior Insulin Therapy on Outcomes of ICU Patients with Diabetes

James S. Krinsley, MD
Stamford Health Medical Group, Stamford, Connecticut, USA

2:40

Transitions to Discharge for Hospitalized Patients with Diabetes

Mary T. Korytkowski, MD
University of Pittsburgh, Pittsburgh, Pennsylvania

2:55

Telehealth to Prevent Readmissions

Daniel J. Rubin, MD, MSc, FACE
Temple University, Philadelphia, Pennsylvania, USA

3:10

Q&A / Panel Discussion

3:30

End of Session / Adjourn

Saturday, April 2, 2022

SESSION 6: COVID AND DIABETES IN THE HOSPITAL (7:00–8:00 AM)

Moderator

Roma Gianchandani, MD
Cedars Sinai Health Systems, Los Angeles, California, USA

7:00

Epidemiology Risks of Diabetes and Stress Hyperglycemia

Francisco J. Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA

7:15

Adaptation of Inpatient Diabetes Management During a Pandemic: From Research to Practice

Amisha Wallia, MD
Northwestern University, Chicago, Illinois, USA

7:30

Mucor: The Black Fungus

Viswanathan Mohan, MD, PhD, DSc
Dr. Mohan's Diabetes Specialities Centre, Chennai, India

7:45

Q&A / Panel Discussion

8:00

Break

SESSION 7: DRUGS FOR DIABETES (8:15–9:35 AM)

Moderator

Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

8:15

Treatment of DKA and HHS

Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Norfolk and Norwich University Hospitals, Norwich, Norfolk, England

8:27

SGLT2 Inhibitors in the Inpatient Setting

Theocharis Koufakis, MD, PhD
AHEPA University Hospital, Thessaloniki, Greece

8:39

Non-Insulin Agents (Besides SGLT2 Inhibitors and Checkpoint Inhibitors)

Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
Emory University, Atlanta, Georgia, USA

8:51

Immune Checkpoint Inhibitors Diabetes Mellitus

Meng H. Tan, MD
University of Michigan, Ann Arbor, Michigan, USA

9:03

Diabetes Drugs to Prevent Hospitalizations for Acute Cardiovascular Events

Vanita R. Aroda, MD
Brigham and Women’s Hospital, Boston, Massachusetts, USA

9:15

Q&A / Panel Discussion

9:35

Break

SESSION 8: CONTINUOUS GLUCOSE MONITORING (9:55–11:15 AM)

Moderator

Ilias K. Spanakis, MD
University of Maryland, Baltimore, Maryland, USA

9:55

Establishing a CGM Program

Athena Philis-Tsimikas, MD
Scripps Whittier Diabetes Institute, San Diego, California, USA

10:10

Protocols and Hospital Administration

Eileen R. Faulds, PhD, MS, RN, FNP-BC, CDCES
The Ohio State University, Columbus, Ohio, USA

10:25

Prevention of Hyperglycemia

Rodolfo J. Galindo, MD, FACE
Emory University, Atlanta, Georgia, USA

10:40

Prevention of Hypoglycemia

Ilias K. Spanakis, MD
University of Maryland, Baltimore, Maryland, USA

10:55

Q&A / Panel Discussion

11:15

Break

SESSION 9: QUALITY IMPROVEMENT (11:35 AM–12:35 PM)

Moderator

Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA

11:35

Hospital Quality Metrics

Gregory H. Gilbert, MD
Mills-Peninsula Medical Center, Burlingame, California, USA

11:50

A Hospitalist Diabetes Care Program

Mihail Zilbermint, MD
Johns Hopkins University, Bethesda, Maryland, USA

12:05

Pharmacy Programs to Improve Quality

Rima Bouajram, PharmD, BCCCP
University of California, San Francisco, San Francisco, California, USA 

12:20

Q&A / Panel Discussion

12:35

Break

SESSION 10: DIABETES CARE AND EDUCATION (12:55–2:15 PM)

Moderator

Jane J. Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA

12:55

Interdisciplinary Inpatient Diabetes Education: Strategies that Succeed 

Jane J. Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA

1:10

Patient Owned Technology: To Wear or not to Wear 

Rebecca Longo, ACNP-BC, CDE
Lahey Hospital & Medical Center, Burlington Massachusetts, USA

1:25

Preparation for Surgery: Preventing Cancellectomies

Shevy Serhofer, DNP, RN, CRNA
Vassar Brothers Medical Center, Poughkeepsie, New York, USA

1:40

Managing Inpatient Nutrition for People with Diabetes: Challenges and Possible Solutions

Rachel Stahl, MS, RD, CDN, CDCES
Weill Cornell Medicine, New York, New York, USA

1:55

Q&A / Panel Discussion

2:15

Break

SESSION 11:
UNITING PEOPLE, PROCESS, AND TECHNOLOGY TO ACHIEVE OPTIMAL GLYCEMIC MANAGEMENT (2:20–3:20 PM)
(SPONSORED BY GLYTEC)

Ineffective glycemic management has consequences that reach far beyond the patient bed, and stakeholders throughout the hospital have a role to play in ensuring the safe and effective treatment of patients with glycemic issues. This session will provide a high-level overview of the "must haves" for creating a best-in-class glycemic management program and the people, processes and technology that are needed to achieve excellence, improve patient safety, and reduce the cost of care.

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

2:20

 Improving Outcomes for People with Diabetes

Jordan Messler, MD, SFHM, FACP   
Glytec, Clearwater, Florida, USA   

3:05

Q&A / Panel Discussion

3:20

End of Session / Adjourn